Activist 13D/13G Filings - Lyell Immunopharma Inc. (LYEL)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-11-12
4:04 pm
Unchanged
13GLyell Immunopharma Inc.
LYEL
VANGUARD GROUP INC10,071,482
3.930%
0
(Unchanged)
View
2024-11-04
1:30 pm
Sale
13GLyell Immunopharma Inc.
LYEL
VANGUARD GROUP INC10,071,482
3.930%
-3,532,545decrease
(-25.97%)
View
2024-10-31
6:00 pm
Purchase
13GLyell Immunopharma Inc.
LYEL
Foresite Capital Fund IV L.P.13,683,858
5.300%
3,683,858increase
(+36.84%)
View
2024-02-14
3:18 pm
Purchase
13GLyell Immunopharma Inc.
LYEL
ARCH Venture Fund IX L.P.36,477,716
14.500%
65,000increase
(+0.18%)
View
2024-02-13
5:08 pm
Purchase
13GLyell Immunopharma Inc.
LYEL
VANGUARD GROUP INC13,604,027
5.400%
1,012,797increase
(+8.04%)
View
2024-01-29
5:25 pm
Purchase
13GLyell Immunopharma Inc.
LYEL
BlackRock Inc.
BLK
14,302,220
5.700%
14,302,220increase
(New Position)
View
2023-02-13
5:02 pm
Sale
13GLyell Immunopharma Inc.
LYEL
Foresite Capital Fund IV L.P.10,000,000
4.000%
-3,282,181decrease
(-24.71%)
View
2023-02-09
11:25 am
Purchase
13GLyell Immunopharma Inc.
LYEL
VANGUARD GROUP INC12,591,230
5.050%
12,591,230increase
(New Position)
View
2022-02-14
4:17 pm
Purchase
13GLyell Immunopharma Inc.
LYEL
MWG Management Ltd.20,162,332
8.380%
20,162,332increase
(New Position)
View
2022-02-14
4:10 pm
Purchase
13GLyell Immunopharma Inc.
LYEL
NEWTON (PTC) Ltd15,093,969
6.280%
15,093,969increase
(New Position)
View
2022-02-14
12:04 pm
Purchase
13GLyell Immunopharma Inc.
LYEL
ARCH Venture Fund IX L.P.36,412,716
15.100%
36,412,716increase
(New Position)
View
2022-02-11
3:10 pm
Purchase
13GLyell Immunopharma Inc.
LYEL
Foresite Capital Fund IV L.P.13,282,181
5.500%
13,282,181increase
(New Position)
View
2022-02-10
4:51 pm
Purchase
13GLyell Immunopharma Inc.
LYEL
GSK plc
GSK
30,253,189
12.600%
30,253,189increase
(New Position)
View